- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT05820386
Haut-zu-Haut-Kontakt während des Transfers vom Kreißsaal zur Neugeborenen-Intensivstation: Auswirkungen auf Frühgeborene und ihre Eltern (TRANSPAPNEO)
Bewertung des Haut-zu-Haut-Kontakts während der Verlegung von sehr frühgeborenen Säuglingen aus dem Kreißsaal in die Neugeborenen-Intensivstation: eine randomisierte, kontrollierte, nicht unterlegene, offene Studie im Vergleich zur Verlegung im Inkubator
Developmental care are recognized as a standard of care for preterm infants in neonatal intensive care units. Regular skin-to skin contacts during the neonatal stay show short and long-term beneficial effects on preterm infants and their parents. Skin-to-skin contact provides hemodynamic and thermal stability in preterm infants. Regarding parents, skin-to-skin contact sustains the parental bonding, and reduces stress and anxiety related to hospitalization. As a result, early skin-to-skin contact has been associated with an improvement of neurological outcome in very preterm infants.
Thermal stability is crucial during the first hour of life in preterm infants. A temperature at admission in the neonatal intensive care unit below 36.5°C or above 37.2°C has been associated with an increase in neonatal morbidity and mortality.
Early skin-to-skin contact between a newborn and his/her mother in the delivery room significantly decreases the occurrence of hypothermia below 35.5°C.
The practice of skin-to-skin transfer from the delivery room is emerging in France. Pilot studies have been carried out by French neonatal teams that showed the feasibility of this practice in late-preterm, near-term and term infants. Although skin-to-skin contact routinely involves very preterm infants in neonatal intensive care units worldwide, the feasibility and safety of skin-to-skin contact during the transfer from delivery room to the neonatal unit is poorly documented in very preterm infants. Previous data of our team showed that transfer of preterm infants with non-invasive ventilation using skin-to-skin contact was feasible and safe but concerns emerged about the thermal conservation during the procedure.
The main hypothesis of this study is that skin-to skin contact during the transfer from the delivery room to the neonatal intensive care unit could prevent heat losses in preterm infants as well as the transfer in incubator. Another hypothesis is that very early skin-to-skin contact could positively influence the neonatal course and the parental experience in the neonatal care unit.
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
-
Angers, Frankreich, 49000
- CHU Angers
-
Orléans, Frankreich, 45000
- Neonatal medicine and intensive care unit, University Hospital, Orléans
-
Toulouse, Frankreich, 31300
- Neonatology service, University Hospital, Toulouse
-
Tours, Frankreich, 37000
- Neonatal and paediatric service, University Hospital, Tours
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Gestational age < 34 weeks
- Singleton pregnancy
- Inborn birth, i.e., in the maternity ward of investigating centres
- Need of hospitalization in the neonatal intensive care unit
- Oral and written information of parents and written parental consent to participate in the study (by the father if the mother is unable to participate)
Exclusion Criteria:
- Single parent or homosexual couple
- Absence of the father in the delivery room
- Parents not speaking French
- Skin temperature of the newborn < 36°C at the time of randomization
- Conditions not allowing the early skin-to-skin contact: omphalocele, gastroschisis, desquamating dermatological conditions (Harlequin syndrome, Collodion)
- Clinical condition requiring a specific transfer mode according to the pediatrician in the delivery room
- Parents under legal protection
- Minor parents
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Sonstiges
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Skin-to-skin contact during the transfer between the delivery room and the neonatal care unit
Preterm infants will be transferred using a direct skin-to-skin contact with their father from the delivery room to the intensive neonatal care. |
For the Skin-to-skin Contact (SSC) transfer, the bare-chested father will seat in a wheelchair. Newborns who will wear only a diaper and a cotton cap or noninvasive ventilation headgear will be placed in the kangaroo position against the father's chest to ensure direct contact with the father's skin. Preterm infants with gestational age less than 33 weeks will be wrapped with their father using plastic bags plus warmed cotton towels. More gestationally mature infants will be wrapped with only warmed cotton wraps. The newborn's heart rate, oxygen saturation and skin temperature will be monitored throughout the procedure. |
|
Aktiver Komparator: Transfer in incubator between the delivery room and the neonatal care unit
Preterm infants will be transferred in an incubator set to 36°C from the delivery room to the intensive neonatal care. |
In the incubator group, infants will be transferred after resuscitation in an incubator with air temperature set to 36°C. The newborn will be laid on his/her back in a polyethylene bag with a cap. The newborn's heart rate, oxygen saturation and skin temperature will be monitored throughout the procedure. |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change in the infant skin temperature due to the transfer procedure
Zeitfenster: During the transfer procedure
|
Fluctuation in the infant skin temperature between the randomization in the delivery room and the admission in the neonatal intensive care unit (NICU) |
During the transfer procedure
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change in the infant's heart rate during the transfer procedure
Zeitfenster: During the transfer procedure
|
Heart rate values during the transfer procedure |
During the transfer procedure
|
|
Occurrence of bradycardia episodes in infant during the transfer procedure
Zeitfenster: During the transfer procedure
|
Rapid decrease in heart rate less than 100 beats/min that lasts at least 10 secondes during the transfer procedure |
During the transfer procedure
|
|
Change in the infant's oxygen saturation during the transfer procedure
Zeitfenster: During the transfer procedure
|
Oxygen saturation values during the transfer procedure |
During the transfer procedure
|
|
Occurrence of desaturation episodes in infant during the transfer procedure
Zeitfenster: During the transfer procedure
|
Decrease in oxygen saturation less than 85% that last at least 10 secondes |
During the transfer procedure
|
|
Change in the infant's fraction of inspired oxygen during the transfer procedure
Zeitfenster: During the transfer procedure
|
Fraction of inspired oxygen values during the transfer procedure |
During the transfer procedure
|
|
Duration of the transfer procedure
Zeitfenster: During the transfer procedure
|
Time (in min) during the transfer procedure |
During the transfer procedure
|
|
First Hydrogen Potential (pH) of the newborn
Zeitfenster: First blood gas in the NICU
|
First assessment of pH in the neonatal intensive care unit (NICU) |
First blood gas in the NICU
|
|
Carbon dioxide partial pressure (pCO2) of the newborn
Zeitfenster: First blood gas in the NICU
|
First assessment of carbon dioxide partial pressure (pCO2) in the neonatal intensive care unit (NICU) |
First blood gas in the NICU
|
|
Blood glucose of the newborn
Zeitfenster: First blood glucose measurement in the NICU
|
First assessment of blood glucose in the neonatal intensive care unit (NICU) |
First blood glucose measurement in the NICU
|
|
Occurence of hypothermia
Zeitfenster: From admission in the neonatal intensive care unit to 30 min later
|
Decrease of skin temperature less than 36°C |
From admission in the neonatal intensive care unit to 30 min later
|
|
Time to the first skin-to-skin contact in the neonatal care unit
Zeitfenster: Postnatal hour when the first skin-to-skin contact will occur in the neonatal care unit
|
Postnatal hour when the first skin-to-skin contact will occur in the neonatal care unit |
Postnatal hour when the first skin-to-skin contact will occur in the neonatal care unit
|
|
Practice of skin-to-skin contact in the neonatal intensive care unit (NICU) during the first week of life
Zeitfenster: During the first 7 days of the stay in the neonatal care unit
|
Frequency of skin-to-skin contact (Postnatal day and hour), length of each skin-to-skin contact, which parent involves in each skin-to-skin contact episode. |
During the first 7 days of the stay in the neonatal care unit
|
|
Quality of parental bond
Zeitfenster: 2 time points: i) Between the infant postnatal day 3 and postnatal day 7, and ii) at the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30
|
Assessment through a maternal questionnaire: Mother-to-Infant Bonding Scale (MIBS) questionnaire (Mother-to-infant bonding scale - Taylor, 2005). Only the infant's mother will be invited to fill out this questionnaire. |
2 time points: i) Between the infant postnatal day 3 and postnatal day 7, and ii) at the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30
|
|
Parental stress
Zeitfenster: 2 time points: i) Between the infant postnatal day 3 and postnatal day 7, and ii) at the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30
|
Parental stress assessed by Perceived Stress Scale (PSS) - Neonatal Intensive Care Unit (NICU) questionnaire (Perceived Stress Scale Neonatal Intensive Care Unit - Miles, 1993). The infant's mother and father will be invited to fill out this questionnaire. |
2 time points: i) Between the infant postnatal day 3 and postnatal day 7, and ii) at the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30
|
|
Parental post-traumatic stress disorder
Zeitfenster: At the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30
|
Parental post-traumatic stress disorder assessed by Perinatal Post traumatic stress disorder Questionnaire (PPQ) - DEMIER, 1996). The infant's mother and father will be invited to fill out this questionnaire. |
At the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30
|
|
Infant growth: Weight
Zeitfenster: At birth and weight at the postmenstrual age of 36 weeks
|
Weight at birth and at the postmenstrual age of 36 weeks |
At birth and weight at the postmenstrual age of 36 weeks
|
|
Infant growth: Height
Zeitfenster: At birth and at the postmenstrual age of 36 weeks
|
Height at birth and at the postmenstrual age of 36 weeks |
At birth and at the postmenstrual age of 36 weeks
|
|
Infant growth: Head circumference
Zeitfenster: At birth and at the postmenstrual age of 36 weeks
|
Head circumference at birth and at the postmenstrual age of 36 weeks |
At birth and at the postmenstrual age of 36 weeks
|
|
Neonatal morbidity and mortality at the postmenstrual age of 36 weeks
Zeitfenster: At the postmenstrual age of 36 weeks
|
Death
|
At the postmenstrual age of 36 weeks
|
|
Modalities of breastfeeding
Zeitfenster: During the NICU stay: infant postnatal day
|
First breastfeeding attempt in the neonatal intensive care unit (NICU) |
During the NICU stay: infant postnatal day
|
|
Modalities of breastfeeding
Zeitfenster: At the postmenstrual age of 36 weeks
|
Presence of complete or partial breastfeeding at the postmenstrual age of 36 weeks |
At the postmenstrual age of 36 weeks
|
|
Mode of infant feeding at the postmenstrual age of 36 weeks
Zeitfenster: At the postmenstrual age of 36 weeks
|
Modes of infant feeding that include breastfeeding, breastmilk given through a bottle, artificial formula |
At the postmenstrual age of 36 weeks
|
Andere Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Self-questionnaires to study parents' experience of their infant hospitalization
Zeitfenster: 2 time points: i) Between the infant postnatal day 3 and postnatal day 7, and ii) at the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30
|
Ancillary study: Self-questionnaires to study parents' experience of their infant hospitalization to assess stress at different times. |
2 time points: i) Between the infant postnatal day 3 and postnatal day 7, and ii) at the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Studienleiter: Nolwenn CLENET, University Hospital, Tours
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- DR210297
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .